IDH1 and central nervous system cancer: In contrast, astrocytoma, IDH-mutant, grade 4 (formerly “secondary GBM”) usually evolves from lower-grade gliomas and is characterized by recurrent mutations in IDH1 and TP53, often accompanied by 19q loss [3,4,5].